The Evolving Landscape of Pulmonary Vascular Disease: Current Advances and Future Directions in Pulmonary Hypertension and Pulmonary Embolism. [PDF]
Life (Basel)Cacia MA, Imbalzano E, Vatrano M.
europepmc +1 more source
Exploring the therapeutic landscape of pulmonary hypertension associated with interstitial lung disease, with a focus on idiopathic pulmonary fibrosis: a narrative review. [PDF]
Front PharmacolReccardini N +8 more
europepmc +1 more source
Heparin-binding protein and Endothelin-1 in critical COVID-19. [PDF]
BMC AnesthesiolHalldorsdottir H +6 more
europepmc +1 more source
VEGF inhibitor-induced proteinuria: the role of hypertension and vascular endothelial dysfunction. [PDF]
J Pharm Health Care SciNihei S, Saito K, Kudo K.
europepmc +1 more source
Abnormalities of liver sinusoidal endothelial cells in primary biliary cholangitis. [PDF]
World J Exp MedThalassinos E +6 more
europepmc +1 more source
Primary Vascular Dysregulation in Normal-Tension Glaucoma: Pathophysiology and Management. [PDF]
CureusBanerjee A, Sarangi PK.
europepmc +1 more source
Zilebesiran, a Small Interfering RNA Therapeutic Targeting Angiotensinogen: Mechanism, Clinical Evidence, Safety, and Implementation Considerations. [PDF]
Life (Basel)Jawaria +5 more
europepmc +1 more source
Venous vascular pharmacology: how does it contribute to heart failure with preserved ejection fraction? [PDF]
Eur Heart J Cardiovasc PharmacotherLineham J, Dagan M, Wang B, Kaye DM.
europepmc +1 more source
Secondary Pharmacology Targets for Pediatric Developmental Safety Assessment of New Drugs: Clinical Pharmacology Considerations. [PDF]
Clin Pharmacol TherBurckart GJ +8 more
europepmc +1 more source